DRReality
2021-12-24

$Pfizer(PFE)$ Worth mentioning again: France cancelled their order for Merck's Covid-19 anti-viral med. The move was prompted by the miserable 30% efficacy and a hope of getting PFE's entry before the end of January 2022. Can you say unbridled demand?

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法